Abbott Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Abbott is engaged in pharmaceuticals and manufacturing healthcare products. It developed the first HIV blood-screening test. Its product portfolio includes Norvir, a treatment for HIV; Synthroid, a synthetic thyroid hormone; Depakote, an anticonvulsant drug; and Humira, a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and more.

Top 100 in Venture Capital in United States
Top 100 in Genetics in United States
Top 100 in Nutrition in United States
Company Highlights
Year Founded

1944

icon-altEmployees

164,500

Location (HQ)

USA

Since Last Funding

13 years 9 months

Monthly Website Visitors

1.1M

icon-altTotal Investment Amt

$6.8M

Last Funding Round

Post Ipo Debt

icon-altMoM Headcount Growth

1.86%

icon-altYoY Headcount Growth

35.23%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Health Diagnostics

Genetics

Medical

Hospitals and Health Care

Manufacturing

Hospital & Health Care

Medical Device

Venture Capital

Emergency Medicine

Nutrition